Objective: Dyslipidemia contribute to considerable increased risk of atherosclerosis and consequent mortality in diabetic patients. An early detection of atherogenic dyslipidemia in type 2 diabetes can help in the management and prevention of atherogenic cardiovascular and cerebrovascular disease. In this article we analyzed the pattern of dyslipidemia and its prevalence in a sample of patients with type 2 diabetes in Zakho, Iraq. Methods: Total cholesterol (TCh), high-density lipoprotein cholesterol (HDL-c) and triglycerides (TG) were measured in 1138 adult patients with type 2 diabetes mellitus, Atherogenic dyslipidemia is defined according to the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (adult Treatment Panel III). Results: Significantly higher cholesterol and triglycerides levels (p<0.001 and p=0.001respectively) were found in age group (36-65 years) compared to younger age group (19-35 years). ASignificantdifference was found with respect to the prevalence of combined dyslipidemia between theage groups (TCh p<0.001, TG p=0.002 and HDL-c p<0.001).Out of 1138 patients, 523(46.7%) were found with combined dyslipidemia. No significant difference was found with respect to the prevalence of isolated dyslipidemia between the age or sex groups. Conclusions: The results confirm that atherogenic diabetic dyslipidemia was seen in about half of the studied patients.Efforts to control combined dyslipidemia by means of drug intervention may be beneficial in type 2 diabetes.